Trial Profile
Daylight Mediated Photodynamic Therapy for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Mar 2019
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary) ; Methyl aminolevulinate
- Indications Actinic keratosis
- Focus Therapeutic Use
- 25 Oct 2018 New trial record
- 17 Oct 2018 Primary endpoint has been met. (Clinical healing of actinic keratoses)
- 17 Oct 2018 Results published in the British Journal of Dermatology